Historical Johnson & Johnson Earnings Call Mentions Tool to Get an Edge on Kalshi

See historical mentions of words said on Johnson & Johnson earnings calls to win on Kalshi's earnings mentions market. See earnings mentions demo here.

Company

Transcripts Shown

Transcript Type

Overall Yes Rate36%

Next Earnings Date

Jan 26, 2027

Latest Transcript

Jul 15, 2026

Predict on Kalshi

Word	Yes	No	Mentions	2026 Q2	2026 Q1	2025 Q4	2025 Q3	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
China	91¢	19¢	26/26(100%)	3	2	3	1	4	5	7	11	18	2	6	8	6	9	8	7	1	8	4	4	5	4	6	10	6	9
Darzalex Faspro	73¢	37¢	9/26(35%)	1	2	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	2	0	1	3	0	0
Caplyta	90¢	19¢	7/26(27%)	4	6	6	7	6	6	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
AI / Artificial Intelligence	39¢	71¢	4/26(15%)	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0
Firefly Bio	90¢	16¢	1/26(4%)	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
You're only seeing data for 5 of 16 words. To see data for all words, subscribe to Prediction Markets Pro. $7.99/week or $19.99/month
Gene Therapy	7¢	99¢
Halda Therapeutics	29¢	81¢
Litigation	75¢	35¢
Nipocalimab / Lupus	26¢	84¢
Ottava	87¢	23¢
Procedure	90¢	17¢
Rybrevant	90¢	13¢
Sail Biomedicines	65¢	54¢
Tariff	84¢	26¢
Tecvayli	90¢	19¢
Vaccine	11¢	98¢

China

Yes

91¢

19¢

26/26(100%)

Quarters w/ Yes

157Total Mentions

2026 Q2Last Mentioned

Darzalex Faspro

Yes

73¢

37¢

9/26(35%)

Quarters w/ Yes

13Total Mentions

2026 Q2Last Mentioned

You're only seeing data for 5 of 16 words. To see data for all words, subscribe to Prediction Markets Pro*.

*$7.99/week or $19.99/month

Caplyta

Yes

90¢

19¢

7/26(27%)

Quarters w/ Yes

41Total Mentions

2026 Q2Last Mentioned

AI / Artificial Intelligence

Yes

39¢

71¢

4/26(15%)

Quarters w/ Yes

4Total Mentions

2026 Q2Last Mentioned

Firefly Bio

Yes

90¢

16¢

1/26(4%)

Quarters w/ Yes

3Total Mentions

2026 Q2Last Mentioned

Gene Therapy

Yes

7¢

99¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Halda Therapeutics

Yes

29¢

81¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Litigation

Yes

75¢

35¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Nipocalimab / Lupus

Yes

26¢

84¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Ottava

Yes

87¢

23¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Procedure

Yes

90¢

17¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Rybrevant

Yes

90¢

13¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Sail Biomedicines

Yes

65¢

54¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Tariff

Yes

84¢

26¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Tecvayli

Yes

90¢

19¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned

Vaccine

Yes

11¢

98¢

Quarters w/ Yes

--Total Mentions

--Last Mentioned